Enhanced productivity of NS0 cells in fed-batch culture with cholesterol nanoparticle supplementation

Authors

  • Yun Wu,

    1. Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017
    2. William G. Lowrie Dept. of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210
    Search for more papers by this author
  • Ningning Ma,

    1. Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017
    Current affiliation:
    1. Sino Biological Inc. 14 Zhong He Street, Suite B-212, BDA, Beijing, China 100176
    Search for more papers by this author
  • Barbara E. Wyslouzil,

    1. William G. Lowrie Dept. of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210
    2. Dept. of Chemistry, The Ohio State University, Columbus, OH 43210
    Search for more papers by this author
  • Jeffrey J. Chalmers,

    1. William G. Lowrie Dept. of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210
    Search for more papers by this author
  • Ellen McCormick,

    1. Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017
    Search for more papers by this author
  • Susan A. Casnocha

    Corresponding author
    1. Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017
    • Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017
    Search for more papers by this author

Abstract

NS0 cells are an important industrial cell line for the production of therapeutic monoclonal antibodies. Culturing these cells is challenging because they are cholesterol auxotrophs, and providing cholesterol to the cells is hampered by the low solubility of lipids in aqueous medium. Limited loading capacity, precipitation, instability, and toxicity are associated with traditional delivery methods that involve solvents or carrier molecules. In this work, nanoparticle cholesterol mixtures (NCM) were produced by electrohydrodynamic spraying and added directly to a cholesterol auxotroph NS0 cell line. Compared to a cholesterol-cyclodextrin solution and a commercial proprietary cholesterol solution, SyntheChol™ NS0 supplement, NCM is significantly less cytotoxic. In the fed batch cell culture process, product titer was increased by 32% when the NCM supplement replaced SyntheChol™ NS0 supplement. An even greater product titer improvement, 64%, was achieved when both NCM and SyntheChol™ NS0 supplements were used in the fed-batch process. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2011

Ancillary